A recent review highlights curcumins cardioprotective and anti-metabolic syndrome potential, emphasizing that nano-curcumin increases curcumins bioavailability and may enhance therapeutic potency ( 5 Clinical translation of curcumin Multiple phase I and II clinical trials have studied curcumin and its nanoformulations for several cancers, including colorectal, pancreatic, and breast, as well as chronic inflammatory illnesses
The results indicated that LBP supplementation reduced the triglyceride/high-density lipoprotein (TG/HDL) ratio, a biomarker linked to cardiovascular disease (CVD) risk [73]
This very large, diverse group of compounds can also be referred to as synthetic cannabinoid receptor agonists
Overall, market momentum favors firms prioritizing validated science, transparent communication, third-party testing, and consistent supply reliability while building long-term consumer trust through education-driven engagement
789 USP11 facilitates autophagy activation by stabilizing beclin-1, which may be the potential mechanism by which USP11 enhances ferroptosis
Daniel Cameron, MD, MPH Lyme disease clinician with over 30 years of experience and past president of ILADS